Can Medical Cannabis Relieve Arachnoiditis? Submitted

New Post Public Reply Private Reply Replies (0) Message Board
Kgem
279
Can Medical Cannabis Relieve Arachnoiditis?


Submitted by Marijuana News on Thu, 06/04/2020 - 09:58

One of the main reasons people look for marijuana is to deal with chronic pain. It does not matter what the cause of the pain is. In fact, sometimes it is hard to pinpoint the cause, but when you find something that brings relief, you tend to stick to it. When you suffer from something like arachnoiditis, you would know what I am talking about. It is a super painful condition where a constant burning sensation is ever-present.

What is Arachnoiditis?

We first have to understand what the arachnoid is to learn what arachnoiditis is. The arachnoid is one of the membranes that surround the nerves of the spinal cord. When these membranes swell and get inflamed, it causes pain. This condition is called arachnoiditis. The swelling of the membrane could be caused by injury, infection, or chronic compression of the spinal cord. Arachnoiditis causes episodes of unbearable pain. It often occurs as a sudden pain. It is not easy to predict where it sits and what the cause of it is. Conventional medications are also not always very effective. This is why something like medical cannabis offers a safer option.

Arachnoid inflammation often leads to scar tissue formation and cause the nerves in the spinal cord to stick together. This hinders the proper functioning of the spinal cord as a result.

What is the Cause of Arachnoiditis?

There are several possible causes of inflammation of the arachnoid membranes. Some of the possible causes are:
Direct injury to the spine

Chemicals – preservatives found in epidural steroid injections are often to blame. The dye in myelograms injected into the surrounding areas of the spinal cord and nerves also could cause damage.

Bacterial or viral infections – viral and fungal meningitis and tuberculosis could cause inflammation of the arachnoid membranes Chronic compression of spinal nerves – chronic degenerative disc disease or advanced spinal stenosis cause constant compression that leads to inflammation. Complications from spinal surgery or other invasive spinal procedures – this could include multiple lumbar punctures.

What Symptoms are there?

As is the case with so many other conditions in the body, the symptoms are not specific. An indication is pain derived from the nerves connected to the lower legs and back in most people. Though pain is the most common symptom, there are more symptoms related to arachnoiditis. These symptoms include the following:

Numbness, tingling, or weakness in the legs

A sensation of insects crawling on your skin or water trickling down your legs

Muscle spasms, cramps, and uncontrollable twitching

Severe shooting pain

Balance problems

Bladder, bowel, and sexual problems

Joint pain, fatigue, and loss of mobility

Sleeping problems

Depression and anxiety

People suffering from arachnoiditis could also have severe pain that goes down to their lower extremities. They might also suffer from hearing problems, severe headaches, vision problems, nausea, and dizziness. Some people also describe the pain like electric shocks. All these symptoms are because of alternation and impediment of the cerebral spinal fluid circulation. It is caused by clumped roots, fibrosis, and scar tissue. The more severe the arachnoiditis is, the more severe the symptoms become. Eventually it causes substantial disability due to constant pain. Finally, a person cannot work anymore.

Why Medical Marijuana is able to Help

Traditionally, medical doctors treat arachnoiditis with conventional pain killers. They focus mostly on the physical symptoms of the condition. They hardly ever take the psychological aspects into consideration, like the fear of extreme pain. This kind of fear could lead to emotional distress. This is where cannabis comes in. It is not just able to treat physical symptoms, but it can also treat emotional problems that would address arachnoiditis from both sides.

One of the main reasons people would opt for medical marijuana is pain relief. Arachnoiditis is not easy to treat. There is no cure and the treatment is limited to overcoming pain. Surgery is not a good option. Epidural steroid injections are also not advisable as they could worsen rather than better the condition. Pain management therapy often is the only way out. Medical cannabis is the safer option of the lot.

Cannabis has strong analgesic properties. Little to no side-effects are reported and cannabidiol helps to reduce inflammation and the tingling and numbing sensations often experienced. Living with chronic pain is super hard as it affects many aspects of your life. Arachnoiditis is not easy to treat. Researchers have now established that cannabis is efficient for treating several medical and pain issues. It is especially effective in treating neuropathic pain, chronic pain, and spasticity. The symptoms treatable with cannabis in arachnoiditis are:

Chronic pain
Depression due to chronic pain
Muscle spasm
Nausea due to chronic pain
Insomnia
Stress and headaches

Conclusion

If you are diagnosed with arachnoiditis, medical cannabis is a safe and effective option to get relief. Anyone of the many ways to use cannabis for medicinal purposes would work.



Source: 420 INTEL newsletter








Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 11

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 7

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 7

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 11

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 4

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 10

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 6

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 10

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 5

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

Chart Industries Transitions to New Leadership in Upcoming Merger

Updated Category News Views 231

Chart Industries Announces Leadership Change Chart Industries (NYSE: GTLS) is taking significant steps toward a future transition as CEO Jill Evanko has announced plans to assume a senior advisor role starting in early 2026. This change comes as she prepares to take on a new executive opportunity within a privately owned company. Evanko has been essential in steering the...

Continue Reading
Understanding Debtors: Insights into Realkredit Danmark A/S

Updated Category News Views 299

Understanding Debtors: Key Insights from Realkredit Danmark A/S At the heart of any effective financial institution is a reliable understanding of its debtors. Realkredit Danmark A/S, a prestigious name in the financial landscape, recently made available a detailed breakdown of its debtors. This information is crucial for various stakeholders, including investors,...

Continue Reading
Cryptocurrency Market Update: Bitcoin Droops under $59K with ETF Inflows Soaring

Updated Category News Views 148

Bitcoin's Recent Performance The cryptocurrency market has been lively lately, especially with Bitcoin recently falling below the $59,000 threshold. Investors had been optimistic, especially since the cryptocurrency saw a remarkable $436 million in net ETF inflows just last week. This significant influx signals that institutional interest in cryptocurrencies is still...

Continue Reading
Enhancing Specialized Care for ARFID Treatment with Emily Program

Updated Category News Views 169

Introduction to The Emily Program and ARFID The Emily Program is making significant strides in specialized care for individuals with Avoidant/Restrictive Food Intake Disorder (ARFID). This condition, often misunderstood, has recently begun to garner more attention from healthcare experts. In response to this need, The Emily Program is offering advanced treatment...

Continue Reading
Investigation of Alleged Securities Fraud at 3D Systems Unfolds

Updated Category News Views 167

Overview of Legal Actions Against 3D Systems Corporation Recently, investors in 3D Systems Corporation have found themselves entangled in a potential securities fraud lawsuit. This case serves as a cautionary tale, highlighting the importance of transparency and integrity in corporate communication. The allegations stem from assertions that the company made misleading...

Continue Reading